Serpin α1proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopy

Protein Science

Volumn 5, Issue 11, 1996, Pages 2226-2235

  Koloczek, Henryk ^a   Banbula, Agnieszka ^b   Salvesen, Guy S ^c   Potempa, Jan ^b  

^a UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c BURNHAM INSTITUTE   (United States)

Author keywords

folding; intrinsic fluorescence; polymerization; 1proteinase inhibitor

Indexed keywords

SERINE PROTEINASE INHIBITOR; TRYPTOPHAN; ALPHA 1 ANTITRYPSIN; ALPHA 1 ANTITRYPSIN LEUKOCYTE ELASTASE COMPLEX; ALPHA 1-ANTITRYPSIN-LEUKOCYTE ELASTASE COMPLEX; LEUKOCYTE ELASTASE; PANCREATIC ELASTASE;

ARTICLE; DENATURATION; ENZYME ACTIVITY; ENZYME INHIBITION; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; SPECTROFLUOROMETRY; CHEMISTRY; HUMAN; MOLECULAR PROBE; PROTEIN CONFORMATION;

ALPHA 1-ANTITRYPSIN; HUMANS; LEUKOCYTE ELASTASE; MOLECULAR PROBES; PANCREATIC ELASTASE; PROTEIN CONFORMATION; SPECTROMETRY, FLUORESCENCE; TRYPTOPHAN;

EID: 0029658224     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560051109     Document Type: Article

References (45)

1. 346-Thr) results in non substrate-like behavior and in polymerization of the molecule. J Biol Chem 268:18088-18094.
2. Baumann U, Bode W, Huber R, Travis J, Potempa J. 1992. Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1 95 Å resolution. J Mol Biol 226:1207-1218
3. Baumann U, Huber R, Bode W, Grosse D, Lesjak M, Laurell CB. 1991. Crystal structure of cleaved human α-antichymotrypsin and its comparison with other serpins. J Mol Biol 218:595-606.
4. Björk I, Nordling K, Larsson I, Olson ST. 1992a. Kinetic characterization of substrate reaction between a complex of antithrombin with synthetic reactive-bond loop tetradecapeptide and four target proteinases of the inhibitor. J Biol Chem 267:19047-19050.
5. Björk I, Nordling K, Olson ST. 1993. Immunologic evidence for insertion of the reactive-bond loop of antithrombin into the a β-sheet of the inhibitor during trapping of target proteinases. Biochemistry 32:6501-6505.
6. 14 region of the putative reactive bond loop of the inhibitor. J Biol Chem 267:1976-1982.
7. Bruce D, Perry DJ, Borg JY, Carrell RW, Wardell MR. 1994. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-Asp). J Clin Invest 94:2265-2274
8. Bruch M, Bieth J. 1986. Influence of elastin on the inhibition of leucocyte elastase by α-1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor. Biochem J 238:269-273.
9. Carrell RW, Evans DL, Stein PE. 1991. Mobile reactive centre of serpins and the control of thrombosis. Nature 353:576-578.
10. Carrell RW, Stein PE. 1996. The biostructural pathology of the serpins: Critical function of sheet opening mechanism. Biol Chem Hoppe-Seyler 377:1-17.
11. Carrell RW, Stein PE, Fermi G, Wardell MR. 1994. Biological implications of a 3 Å structure of dimeric antithrombin. Structure 2:257-270.
12. Demchenko AP. 1988. Red-edge-excitation fluorescence spectroscopy of single-tryptophan proteins. Eur Biophys J 16:121-129.
13. Eldering E, Verpy E, Roem D, Meo T, Tosi M. 1995. COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization. J Biol Chem 270:2579-2587.
14. Engh RA, Huber R, Bode W, Schulze AJ. 1995. Divining the serpin inhibition mechanism: A suicide substrate "springe"? Trends Biotech 13:503-510.
15. Goldenberg DP. 1989. Analysis of protein conformation by gel electrophoresis. In: Creighton TE, ed. Protein structure: A practical approach. New York: IRL Press. pp 225-250.
16. Hekman CM, Laskutoff DJ. 1995. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. J Biol Chem 260:11581-11587.
17. Hopkins PCR, Carrell RW, Stone SR. 1993. Effect of mutations in the hinge region of serpins. Biochemistry 32:7650-7657.
18. Jain N, Brickenden A, Lorimer I, Ball EH, Sanwal BD. 1994. Interaction of procollagen I and other collagens with colligin. Biochem J 304:61-68.
19. Katz DS, Christianson DW. 1993. Modeling the uncleaved serpin antichymotrypsin and its chymotrypsin complex. Protein Eng 6:701-709.
20. 1-antitrypsin suppresses the folding defect of the Z-type variant J Biol Chem 270:8597-8601.
21. 1-proteinase inhibitor. Biochim Biophys Acta 1073:619-625.
22. Lawrence DA, Olson ST, Palaniappan S, Ginsburg D. 1994. Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition. J Biol Chem 209:27657-27662.
23. Löbermann H, Takuoha R, Deisenhofer J, Huber R. 1984. Human α-1-proteinase inhibitor: Crystal structure analysis of two modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol 177:731-757.
24. 1-antitrypsin. J Biol Chem 270:5282-5288.
25. 52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J Biol Chem 270:16864-16870.
26. 1-antitrypsin accumulation in the liver. Nature 357:605-607.
27. 1-antitrypsin. Biochemistry 32:500-508.
28. 53-Phe). Further evidence for intercellular loop-sheet polymerization. J Biol Chem 268:15333-15335.
29. Mast AE, Enghild JJ, Salvesen G. 1992. Conformation of the reactive site loop of α-proteinase inhibitor probed by limited proteolysis. Biochemistry 31:2720-2728.
30. Mikus P, Ny T 1996. Intracellular polymerization of the serpin plasminogen activator inhibitor type 2. J Biol Chem 271:10048-10053.
31. Mikus P, Urano T, Liljeström P, Ny T. 1993. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterization of the recombinant intracellular and extra-cellular forms. Eur J Biochem 218:1071-1082.
32. Mottonen J, Strand A, Symersky J, Sweet RM, Danley DE, Geoghegan KF, Gerard RD, Goldsmith EJ. 1992. Structural basis of latency in plasminogen activator inhibitor-1. Nature 355:270-273.
33. Mourey L, Samama JP, Delarue M, Petitou M, Choay J, Moras D. 1993. Crystal structure of cleaved bovine antithrombin III at 3.2 Å resolution. J Mol Biol 232:223-241
34. Schreuder HA, de Boer B, Dijkema R, Mulders J, Theunissen HJM, Grootenhuis PDJ, Hol WGJ. 1994. The intact and cleaved human antithrombin III complex as a model for serine-proteinase interactions. Nature Struct Biol 1:48-54.
35. 1-antitrypsin by a peptide sequentially similar to β-strand s4A. Eur J Biochem 194:51-56.
36. 1proteinase inhibitor in β-sheet A. Biochemistry 31:7560-7565.
37. 1-antitrypsin deficiency variants. J Biol Chem 270:8393-8396.
38. Skriver K, Wikoff WR, Patston PA, Tausk F, Schapira M, Kaplan AP, Bock SC 1991. Substrate properties of C1 inhibitor Ma (alanine 434-glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor inhibitor/substrate status. J Biol Chem 266:9216-9221.
39. Song HK, Lee KN, Kwon KS, Yu MH, Suh SW. 1995. Crystal structure of an uncleaved α1-antitrypsin reveals the conformation of its inhibitory reactive loop. FEBS Lett 377:150-154.
40. Stein PE, Leslie AGW, Finch JT, Turnell WG, McLaughlin PJ, Carrell RW. 1990. Crystal structure of ovalbumin as a model for the reactive centre of serpins. Nature 247:99-102.
41. Stryjewski W, Wasylewski Z. 1986. The resolution of heterogeneous fluorescence of multitryptophan-containing proteins studied by a fluorescence-quenching method. Eur J Biochem 158:547-553.
42. Wasylewski Z, Koloczek H, Wasniowska A. 1988. Fluorescence-quenching-resolved spectroscopy of proteins. Eur J Biochem 172:719-724.
43. Wei A, Rubin H, Cooperman BS, Christianson DW. 1994. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop. Nature Struct Biol 1:251-258.
44. Wright HT, Qian HX, Huber R. 1990. Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. J Mol Biol 213:513-528.
45. Wright HT, Scarsdale NJ. 1995. Structural basis for serpin inhibitory activity. Proteins Struct Funct Genet 22:210-225